| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 58.8% | 20/34 |
| Female | 41.2% | 14/34 |
| Indifferent | 0% | 0/34 |
| Unknown | 0% | 0/34 |
| General | ||
| 7.1% | 1/14 | |
| 6.7% | 1/15 | |
| 7.1% | 1/14 | |
| 23.5% | 4/17 | |
| 13.3% | 2/15 | |
| 30.8% | 8/26 | |
| 80% | 12/15 | |
| 94.1% | 32/34 | |
| 79.4% | 27/34 | |
| 53.8% | 7/13 | |
| Neurology | ||
| 79.4% | 27/34 | |
| 79.4% | 27/34 | |
| 55.9% | 19/34 | |
| Facial abnormalities | ||
| 17.6% | 6/34 | |
| 44.1% | 15/34 | |
| 41.2% | 14/34 | |
| 41.2% | 14/34 | |
| Visual and hearing impairments | ||
| 8.8% | 3/34 | |
| 55.9% | 19/34 | |
| Heart | ||
| 38.2% | 13/34 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/12 |
| Gastrointestinal | ||
| 61.8% | 21/34 | |
| Urogenital | ||
| 41.2% | 14/34 | |
| Skeleton | ||
| 61.8% | 21/34 | |
| Skin / Hair / Nails | ||
| 35.3% | 12/34 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/34 |
| Metabolic | 0% | 0/34 |
| 14.7% | 5/34 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/34 |
| Inheritance | ||
| 100% | 3/3 | |
